Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Diseases × bicalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 115 Breast Neoplasms 10 Neoplasm Metastasis 6 Neoplasms 5 Triple Negative Breast Neoplasms 4 Bulbo-Spinal Atrophy, X-Linked 4 Salivary Gland Neoplasms 2 Osteoporosis 2 Lower Urinary Tract Symptoms 2 Hirsutism 2 Thrombocytosis 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Stage I Prostate Adenocarcinoma 1 Sexual Dysfunction, Physiological 1 Recurrence 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Primary Dysautonomias 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Castrate Metastatic Prostate Cancer 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1

Interventions

fludarabine 2 Busulfan 2 thymoglobulin 1 fludarabine phosphate 1 bicalutamide 1 Testosterone 1 Saline Solution 1 Powders 1 Nutrition Assessment 1 Metformin 1 Mesna 1 Melphalan 1 Magnetic Resonance Imaging 1 Influenza Vaccines 1 Honey 1 Heparin 1 Gonadotropin-Releasing Hormone 1 Gastric Bypass 1 Exercise 1 Eating 1 Cyclophosphamide 1 Clofarabine 1 Caloric Restriction 1 Antineoplastic Agents 1 Antilymphocyte Serum 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05647356 2022-12-12

REFUEL PCOS

Royal College of Surgeons, Ireland

Phase NA Unknown

Metabolic Diseases, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡